Status:
UNKNOWN
Umbilical Cord Mesenchymal Stem Cells Infusion Via Hepatic Artery in Cirrhosis Patients
Lead Sponsor:
Qingdao University
Conditions:
Liver Cirrhosis
Radiology
Eligibility:
All Genders
18-70 years
Phase:
PHASE1
PHASE2
Brief Summary
The purpose of this study is to investigate the efficacy of umbilical cord mesenchymal stem cells (MSCs) infusion via hepatic artery in the treatment of liver cirrhosis.
Detailed Description
To investigate the efficacy of umbilical cord mesenchymal stem cells (MSCs) infusion via hepatic artery in the treatment of liver cirrhosis. Patients with liver cirrhosis were randomly separated into ...
Eligibility Criteria
Inclusion
- Aged 18\~70 years.
- Liver cirrhosis
- written consent
Exclusion
- The end-stage of liver cirrhosis.
- Severe problems in other vital organs(e.g.the heart,renal or lungs).
- Hepatocellular carcinoma or other malignancies
- Pregnancy
- sepsis
- Presence of significant extrahepatic biliary disease (e.g. CBD stone, PSC, etc.)
- Cardiac, renal or respiratory failure
- Active thrombosis of the portal or hepatic veins
Key Trial Info
Start Date :
October 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2012
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT01224327
Start Date
October 1 2010
End Date
December 1 2012
Last Update
October 20 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Stem Cell Research Center of Medical School Hospital of Qingdao University
Qingdao, Shandong, China, 266003